CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- 4 Open-market sale SVP,General Counsel & Sec. sold 17,500 shares at $11.00 ($192,500)
- 4 Open-market buy Director bought 50,000 shares at an average $8.12 ($405,750)
- 4 Open-market sale EVP, CFO & CBO sold 21,450 shares at an average $11.02 ($236,345)
- 4 Open-market sale President & CEO sold 34,281 shares at an average $11.02 ($377,733)
- 4 Open-market sale SVP & Chief Operating Officer sold 1,600 shares at $12.03 ($19,248)
- 4 Open-market sale SVP,General Counsel & Sec. sold 17,500 shares at $12.00 ($210,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP, Chief Accounting Officer sold 17,000 shares at $12.51 ($212,670)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 202,634 shares (option exercise)
- 4 Option exercise Director acquired 202,634 shares (option exercise)
- 4 Option exercise 10% owner acquired 202,634 shares (option exercise)
- 4 Open-market sale Director sold 1,000,000 shares at $10.00 ($10,000,000)
- 4 Open-market sale Director sold 1,000,000 shares at $10.00 ($10,000,000)
- 4 Open-market sale 10% owner sold 1,000,000 shares at $10.00 ($10,000,000)
Page 10 of 14 · 264 filings